Valvuloplasty stands as a pivotal medical intervention dedicated to addressing valvular heart disease, a condition marked by the impairment or constriction of heart valves. In this sophisticated procedure, a specialized catheter, housing a deflated balloon, navigates through the intricate network of blood vessels until it reaches the targeted heart valve in need of correction. With precision and care, the balloon is then inflated, strategically widening the narrowed valve. This meticulous approach facilitates improved blood circulation, mitigating symptoms associated with valvular disorders and promoting overall cardiovascular health. Distinguished by its minimally invasive nature, valvuloplasty presents a compelling alternative to the conventional realm of open-heart surgery. This innovation translates to shorter recovery periods and diminished postoperative discomfort for patients undergoing the procedure. As medical advancements continue to propel the field forward, valvuloplasty emerges as a beacon of hope for individuals grappling with valvular heart disease, offering a less invasive avenue for restoring cardiac function and enhancing the quality of life.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation